Menu

• Ask a Health Expert about ESCHERICHIA SEPSIS
• Post Your Side Effect related to ESCHERICHIA SEPSIS
• ESCHERICHIA SEPSIS and FDA Warnings
• ESCHERICHIA SEPSIS in Patients Wiki
• Report ESCHERICHIA SEPSIS in Drug Side Effect Survey

ESCHERICHIA SEPSIS side effect

What is ESCHERICHIA SEPSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Enbrel Side Effects Report #5672243-0
Physician from TAIWAN, PROVINCE OF CHINA reported ENBREL problem on Mar 06, 2008. Female patient, weighting 121.3 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, multi-organ failure, necrotising fasciitis, serratia sepsis, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, ASPIRIN, FUROSEMIDE, DIPYRIDAMOLE. Patient died on 03/03/2008.

Revlimid Side Effects Report #5672379-4
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Mar 18, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, urinary tract infection enterococcal, . REVLIMID dosage: 15MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, NEURONTIN, REGLAN, ATIVAN, LORTAB. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5548395-X
Consumer or non-health professional from BELGIUM reported NOVANTRONE problem on Nov 27, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, folliculitis, vasculitis, . NOVANTRONE dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTOSAR, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5573768-9
GEMTUZUMAB OZOGAMICIN problem was reported by a Physician from BELGIUM on Dec 20, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, haematemesis, stenotrophomonas sepsis, thrombocytopenia, . GEMTUZUMAB OZOGAMICIN dosage: 5.75 MG (CUMULATIVE DOSE 7.25 MG) FREQUENCY NOT SPECIFIED. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, PROLOPA. Patient died on 10/26/2007.


Gemtuzumab Side Effects Report #5526700-8
Physician from BELGIUM reported GEMTUZUMAB OZOGAMICIN problem on Nov 20, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, folliculitis, vasculitis, . GEMTUZUMAB OZOGAMICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTOSAR, MITOXANTRONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5473912-8
RITUXIMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 06, 2007. Male patient, weighting 123.5 lb, was diagnosed with t-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, . RITUXIMAB dosage: 600 MG, UNK. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5445622-4
Physician from UNITED STATES reported REVLIMID problem on Aug 28, 2007. Male patient, 81 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, neutropenia, pneumonia, renal failure acute, . REVLIMID dosage: 20 MG, 2 IN 1 D, ORAL. Patient died on 02/12/2007.

Nitric Side Effects Report #5448208-0
NITRIC OXIDE problem was reported by a Physician from NETHERLANDS on Aug 30, 2007. Male patient, weighting 1.54 lb, was diagnosed with lung disorder, prophylaxis and was treated with NITRIC OXIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, intraventricular haemorrhage neonatal, meningitis bacterial, patent ductus arteriosus, . NITRIC OXIDE dosage: unknown. During the same period patient was treated with NITRIC OXIDE, CEFOTAXIME, GENTAMICIN, FLUCLOXACILLINE. Patient was hospitalized and became disabled. Patient recovered.

Enbrel Side Effects Report #5450321-9
Health Professional from FRANCE reported ENBREL problem on Sept 03, 2007. Male patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, escherichia urinary tract infection, prostate infection, renal impairment, . ENBREL dosage: unknown. During the same period patient was treated with HYPERIUM, LERCANIDIPINE HYDROCHLORIDE, CORTANCYL. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #5450580-2
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Sept 06, 2007. Male patient, weighting 123.5 lb, was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, . RITUXIMAB dosage: 600 MG, UNK. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died on 07/31/2007.

Etoposide Side Effects Report #5407419-0
Physician from BELGIUM reported ETOPOSIDE problem on July 27, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, . ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.

Enalapril Side Effects Report #5390566-X
ENALAPRIL MALEATE problem was reported by a Health Professional from INDIA on May 17, 2007. Male patient, weighting 6.06 lb, was diagnosed with cardiac failure congestive and was treated with ENALAPRIL MALEATE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, peritoneal dialysis, peritonitis, renal failure neonatal, . ENALAPRIL MALEATE dosage: 0,1 MG/KG (0,1 MG/KG,1 IN 1 D),ORAL. During the same period patient was treated with FUROSEMIDE, DIGOXIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5398979-7
Physician from BELGIUM reported ETOPOSIDE problem on July 19, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, . ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.

Enalapril Side Effects Report #5390566-X
ENALAPRIL MALEATE problem was reported by a Health Professional from INDIA on May 17, 2007. Male patient, weighting 6.06 lb, was diagnosed with cardiac failure congestive and was treated with ENALAPRIL MALEATE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, peritoneal dialysis, peritonitis, renal failure neonatal, . ENALAPRIL MALEATE dosage: 0,1 MG/KG (0,1 MG/KG,1 IN 1 D),ORAL. During the same period patient was treated with FUROSEMIDE, DIGOXIN. Patient was hospitalized. Patient recovered.


Etoposide Side Effects Report #5398979-7
Physician from BELGIUM reported ETOPOSIDE problem on July 19, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, . ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.

Stalevo Side Effects Report #5732435-9
STALEVO problem was reported by a Health Professional from FRANCE on Apr 22, 2008. Female patient, 78 years of age, was diagnosed with parkinson's disease, prophylaxis, escherichia sepsis, anxiety, pain and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, faecaloma, orthostatic hypotension, subileus, . STALEVO dosage: 500/125/1000 MG, ORAL. During the same period patient was treated with LOVENOX, ROCEPHIN, LEXOMIL, ACETAMINOPHEN, NULYTELY, LEVOTHYROXINE, VASTAREL BIOPHARMA. Patient was hospitalized. Patient recovered.

Pegasys Side Effects Report #5695058-6
Health Professional from CANADA reported PEGASYS problem on Jan 21, 2008. Female patient, weighting 143.3 lb, was diagnosed with hepatitis c, insomnia and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, uterine polyp, . PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, EPREX, IMMOVANE. Patient was hospitalized. Patient died on 03/02/2008.

Pegasys Side Effects Report #5707123-5
PEGASYS problem was reported by a Health Professional from CANADA on Apr 08, 2008. Female patient, weighting 143.3 lb, was diagnosed with hepatitis c, insomnia and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, haemoglobin decreased, platelet count decreased, uterine polyp, . PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN, EPREX, IMMOVANE. Patient was hospitalized. Patient died on 03/02/2008.

Enfuvirtide Side Effects Report #5342394-9
Physician from UNITED KINGDOM reported ENFUVIRTIDE problem on May 21, 2007. Male patient, 54 years of age, was treated with ENFUVIRTIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, pancytopenia, rectal haemorrhage, . ENFUVIRTIDE dosage: unknown. During the same period patient was treated with DARUNAVIR, RITONAVIR, EMTRICITABINE. Patient was hospitalized and became disabled. Patient died on 04/29/2007.


Truvada Side Effects Report #5342775-3
TRUVADA problem was reported by a Health Professional from UNITED KINGDOM on May 21, 2007. Male patient, 54 years of age, was diagnosed with hiv infection and was treated with TRUVADA. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, pancytopenia, rectal haemorrhage, . TRUVADA dosage: unknown. During the same period patient was treated with PREZISTA, RITONAVIR, ENFUVIRTIDE, OXYCODONE, BACTRIM DS, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 04/29/2007.

Prezista Side Effects Report #5322632-9
Physician from UNITED STATES reported PREZISTA problem on May 08, 2007. Male patient, 54 years of age, was diagnosed with hiv infection and was treated with PREZISTA. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, pancytopenia, rectal haemorrhage, . PREZISTA dosage: unknown. During the same period patient was treated with RITONAVIR, TRUVADA, ENFUVIRTIDE, EPOETIN ALFA, OXYCODONE, BACTRIM DS. Patient was hospitalized and became disabled. Patient died on 04/29/2007.

Cytarabine Side Effects Report #5341976-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Male patient, weighting 182.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, hypotension, neutropenia, respiratory failure, . CYTARABINE dosage: 34740 MG. Patient was hospitalized. Patient recovered.

Triomune Side Effects Report #5289810-9
Consumer or non-health professional from reported TRIOMUNE problem on Apr 03, 2007. Female patient was diagnosed with hiv infection and was treated with TRIOMUNE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, . TRIOMUNE dosage: NEVIRAPINE 400 MG / STAVUDINE 60 OR 80 MG / LAMIVUDINE 300 MG. Patient died.

Dacogen Side Effects Report #5255475-5
DACOGEN problem was reported by a Physician from UNITED STATES on Sept 25, 2006. Male patient, 75 years of age, weighting 207.2 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, off label use, pancytopenia, thrombocytopenia, . DACOGEN dosage: 20 MG/M**2; QD; IV. During the same period patient was treated with NEULASTA. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5661668-5
Health Professional from PERU reported CAMPATH problem on Feb 29, 2008. Female patient was diagnosed with mycosis fungoides recurrent, antibiotic prophylaxis, antiviral prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, escherichia sepsis, genital herpes, nervous system disorder, neutropenia, pneumonia cytomegaloviral, pyrexia, thrombocytopenia, urosepsis, . CAMPATH dosage: TOTAL DAILY DOSE: 3 MG. During the same period patient was treated with TRIMETHOPRIM, ACYCLOVIR. Patient died.

Campath Side Effects Report #5662395-0
CAMPATH problem was reported by a Health Professional from PERU on Feb 29, 2008. Female patient was diagnosed with mycosis fungoides recurrent, antibiotic prophylaxis, antiviral prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, escherichia sepsis, genital herpes, nervous system disorder, neutropenia, pneumonia cytomegaloviral, pyrexia, thrombocytopenia, urosepsis, . CAMPATH dosage: TOTAL DAILY DOSE: 3 MG. During the same period patient was treated with TRIMETHOPRIM, ACYCLOVIR. Patient died.

Dasatinib Side Effects Report #5612107-1
Health Professional from ISRAEL reported DASATINIB problem on Jan 30, 2008. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DASATINIB. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, escherichia sepsis, lung infiltration, respiratory syncytial virus infection, . DASATINIB dosage: unknown. During the same period patient was treated with ACYCLOVIR, TAZOCIN, CELLCEPT, PREDNISONE, RECITAL, VABEN, MORPHINE, LASIX. Patient died.

Humira Side Effects Report #5626499-0
HUMIRA problem was reported by a Consumer or non-health professional from GERMANY on Feb 04, 2008. Female patient, weighting 156.5 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: anaemia, escherichia sepsis, renal failure acute, rheumatoid arthritis, thrombocytopenia, thrombosis, urinary tract infection, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5635077-9
Consumer or non-health professional from GERMANY reported HUMIRA problem on Feb 12, 2008. Female patient, weighting 156.5 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: anaemia, escherichia sepsis, renal failure acute, rheumatoid arthritis, thrombocytopenia, thrombosis, urinary tract infection, urosepsis, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, KINERET. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5610323-6
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 23, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, escherichia sepsis, myelodysplastic syndrome, neutropenic sepsis, . REVLIMID dosage: 10 MG, 21 DAYS OF 28 DAYS, ORAL. During the same period patient was treated with DECITABINE. Patient died on 10/10/2007.

Humira Side Effects Report #5555936-5
Consumer or non-health professional from GERMANY reported HUMIRA problem on Dec 03, 2007. Female patient, weighting 156.5 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: anaemia, escherichia sepsis, renal failure acute, rheumatoid arthritis, thrombocytopenia, thrombosis, urinary tract infection, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Zyprexa Side Effects Report #5513825-6
ZYPREXA problem was reported by a Consumer or non-health professional from FRANCE on Nov 02, 2007. Female patient was diagnosed with brief psychotic disorder with marked stressors and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, haematoma, hypotonia neonatal, meconium ileus, necrotising enterocolitis neonatal, oedema, urine sodium increased, weight decrease neonatal, . ZYPREXA dosage: 10 MG, DAILY (1/D). During the same period patient was treated with TERCIAN, TRIMEPRAZINE, DEROXAT. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5523809-X
Consumer or non-health professional from GERMANY reported HUMIRA problem on Nov 13, 2007. Female patient, weighting 156.5 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: anaemia, escherichia sepsis, renal failure acute, rheumatoid arthritis, thrombocytopenia, thrombosis, urinary tract infection, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5479948-5
RITUXIMAB problem was reported by a Health Professional from FRANCE on Oct 03, 2007. Female patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: aplasia, escherichia sepsis, haematuria, . RITUXIMAB dosage: 700 MG/KG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.

Zyprexa Side Effects Report #5502698-3
Physician from FRANCE reported ZYPREXA problem on Oct 23, 2007. Female patient, weighting 6.94 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, hypotonia neonatal, meconium ileus, necrotising enterocolitis neonatal, neonatal respiratory distress syndrome, . ZYPREXA dosage: unknown. During the same period patient was treated with TERCIAN, DEROXAT, THERALENE. Patient recovered.

Rituximab Side Effects Report #5468889-5
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Sept 17, 2007. Male patient, weighting 123.5 lb, was diagnosed with t-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, escherichia sepsis, febrile neutropenia, haemodynamic instability, ileal perforation, peritonitis, pneumoperitoneum, rectal perforation, . RITUXIMAB dosage: 600 MG, UNK. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient died on 07/31/2007.

Erbitux Side Effects Report #5419712-6
Physician from GERMANY reported ERBITUX problem on Aug 13, 2007. Male patient, 71 years of age, was diagnosed with laryngeal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, escherichia sepsis, peripheral arterial occlusive disease, . ERBITUX dosage: unknown. During the same period patient was treated with MARCUMAR, PARACETAMOL, NIFEDIPINE, SIMVASTATIN, AMIODARONE. Patient was hospitalized and became disabled. Patient recovered.

Tacrolimus Side Effects Report #5759169-9
TACROLIMUS problem was reported by a Physician from JAPAN on May 22, 2008. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus antigen positive, escherichia sepsis, . TACROLIMUS dosage: 0.03 MG/KG, CONTINUOUS, IV NOS. During the same period patient was treated with NEUPOGEN, METHOTREXATE, MYCOPHEOLATE MOFETIL. Patient died.

Monozeclar Side Effects Report #5754403-3
Health Professional from FRANCE reported MONOZECLAR problem on May 27, 2008. Female patient, weighting 187.4 lb, was diagnosed with bronchopneumopathy, atrial fibrillation and was treated with MONOZECLAR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, escherichia sepsis, fall, flank pain, heart rate irregular, mitral valve incompetence, nephropathy, rales, renal failure acute, . MONOZECLAR dosage: unknown. During the same period patient was treated with CLAVULANATE POTASSIUM, FLUINDIONE, AMIODARONE, LOSARTAN POTASSIUM, ESCITALOPRAM. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5341788-5
GEMZAR problem was reported by a Physician from FRANCE on May 28, 2007. Female patient, 63 years of age, was diagnosed with breast cancer metastatic, prophylaxis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: angiodermatitis, escherichia sepsis, haemolytic uraemic syndrome, livedo reticularis, . GEMZAR dosage: 2000 MG, OTHER. During the same period patient was treated with SERESTA, OSMOTAN, ZOFRAN, DAFLON. Patient recovered.

Zofran Side Effects Report #5322296-4
Consumer or non-health professional from FRANCE reported ZOFRAN problem on May 10, 2007. Female patient, 63 years of age, was diagnosed with prophylaxis, breast cancer and was treated with ZOFRAN. After drug was administered, patient experienced the following problems/side effects: angiodermatitis, escherichia sepsis, haemolytic anaemia, haemolytic uraemic syndrome, lividity, red blood cell schistocytes present, renal failure, skin ulcer, thrombocytopenia, . ZOFRAN dosage: unknown. During the same period patient was treated with SERESTA, OSMOTAN, DAFLON, GEMZAR. Patient recovered.

Ranibizumab Side Effects Report #5309119-4
RANIBIZUMAB problem was reported by a Physician from UNITED STATES on Apr 20, 2007. Male patient was diagnosed with choroidal neovascularisation and was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: confusional state, escherichia sepsis, haemorrhage, laceration, myocardial infarction, nausea, renal failure, respiratory distress, . RANIBIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.

Zophren Side Effects Report #5310065-0
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Apr 19, 2007. Female patient, 63 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: angiodermatitis, escherichia sepsis, haemolytic anaemia, haemolytic uraemic syndrome, lividity, necrosis, paraneoplastic syndrome, red blood cell schistocytes present, renal failure, . ZOPHREN dosage: unknown. During the same period patient was treated with SERESTA, OSMOTAN, DAFLON, GEMZAR. Patient recovered.

Revlimid Side Effects Report #5315286-9
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Apr 18, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, escherichia sepsis, . REVLIMID dosage: unknown. During the same period patient was treated with ANTIBIOTIC TREATMENT. Patient recovered.

Novantrone Side Effects Report #5261724-X
Consumer or non-health professional from ITALY reported NOVANTRONE problem on Feb 26, 2007. Female patient, 67 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, escherichia sepsis, multi-organ failure, septic shock, . NOVANTRONE dosage: 10 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, AMIKACIN, PIPERACILLIN, TAZOBACTAM. Patient died.

Orencia Side Effects Report #5682441-8
ORENCIA problem was reported by a Physician from CANADA on Mar 20, 2008. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis and was treated with ORENCIA. After drug was administered, patient experienced the following problems/side effects: asthenia, depression, escherichia sepsis, fall, fatigue, myocardial infarction, neutropenia, retching, rib fracture, . ORENCIA dosage: unknown. During the same period patient was treated with METHOTREXATE, DILANTIN, PLAVIX, INSULIN, ADALAT, LOPRESSOR, ACTONEL, LIPITOR. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5628979-0
Physician from UNITED STATES reported REVLIMID problem on Feb 07, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, disease progression, escherichia sepsis, fall, myelodysplastic syndrome, neutropenic sepsis, pollakiuria, refusal of treatment by patient, renal failure, . REVLIMID dosage: 10 MG, 21 DAYS OF 28 DAYS, ORAL. During the same period patient was treated with DECITABINE, PRBC, CHLORIDE. Patient died on 10/07/2007.

Imatinib Side Effects Report #5595694-1
IMATINIB problem was reported by a Physician from FRANCE on Jan 15, 2008. Male patient, 58 years of age, weighting 183.0 lb, was diagnosed with acute lymphocytic leukaemia, diabetes mellitus, prophylaxis and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, aplasia, escherichia sepsis, hypotension, pyrexia, renal failure, septic shock, . IMATINIB dosage: 400 MG, BID. During the same period patient was treated with NOVOLOG, VALACYCLOVIR, NEXIUM, METFORMIN, ARACYTINE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5474332-2
Physician from FRANCE reported IMATINIB problem on Sept 25, 2007. Male patient, 58 years of age, weighting 183.0 lb, was diagnosed with acute lymphocytic leukaemia, diabetes mellitus, prophylaxis and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, aplasia, escherichia sepsis, hypotension, pyrexia, renal failure, septic shock, . IMATINIB dosage: 400 MG, BID. During the same period patient was treated with NOVOLOG, ZELITREX, NEXIUM, METFORMIN, CYTARABINE. Patient was hospitalized. Patient recovered.

Panaldine Side Effects Report #5455059-X
PANALDINE problem was reported by a Consumer or non-health professional from JAPAN on Aug 30, 2007. Female patient, 74 years of age, weighting 99.21 lb, was diagnosed with ruptured cerebral aneurysm, hypertension and was treated with PANALDINE. After drug was administered, patient experienced the following problems/side effects: coma hepatic, convulsion, escherichia sepsis, gastric ulcer haemorrhage, gastrointestinal haemorrhage, haematemesis, hepatic failure, hepatitis fulminant, hepatorenal syndrome, . PANALDINE dosage: 200 MG (100 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with OLMESARTAN MEDOXOMIL, MUCOSTA, NORVASC. Patient was hospitalized. Patient died on 08/11/2007.

Erbitux Side Effects Report #5414982-2
Physician from GERMANY reported ERBITUX problem on Aug 06, 2007. Male patient, 71 years of age, was diagnosed with laryngeal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, escherichia sepsis, peripheral arterial occlusive disease, . ERBITUX dosage: unknown. During the same period patient was treated with MARCUMAR, PARACETAMOL, NIFEDIPINE, SIMVASTATIN, AMIODARONE. Patient was hospitalized and became disabled. Patient died on 06/16/2007.